Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Escudier, Bernard J.
Iacovelli, Roberto
Lanoy, Emilie
Albiges, Laurence
Fizazi, Karim
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Roma La Sapienza, Deparment Radiol Oncol & Human Pathol, Oncol Unit, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
397
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
    Jeppesen, A. N.
    Jensen, H. K.
    Donskov, F.
    Marcussen, N.
    von der Maase, H.
    BRITISH JOURNAL OF CANCER, 2010, 102 (05) : 867 - 872
  • [32] External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Yu, Changhong
    Kattan, Michael W.
    Hutson, Thomas E.
    Hudes, Gary R.
    Yuan, Jinyu
    Valota, Olga
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma
    Zhang, Fan
    Xie, Yongpeng
    Ma, Xin
    Gu, Liangyou
    Li, Hongzhao
    Li, Xintao
    Guo, Gang
    Zhang, Xu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (03) : 184.e9 - 184.e17
  • [34] Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies
    Landonio, G
    Baiocchi, C
    Ferrari, M
    Gottardi, O
    Majno, M
    Scanzi, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 468 - 468
  • [35] Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).
    Luo, Jia
    Podolak, Jennifer
    Degnin, Catherine
    Chen, Yiyi
    Robinson, Kyle William
    Pukay, Marina
    Schilling, Amy
    Poage, Cara
    Thomas, George V.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Biological toxicity as a predictive factor of efficacy in metastatic renal cell carcinoma (mRCC) treated with sunitinib
    Guillabert, P.
    Elaidi, R. T.
    Teghom, C.
    Medioni, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S651 - S651
  • [37] Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Suppiah, Revathi
    Shaheen, Philip E.
    Elson, Paul
    Misbah, Seema A.
    Wood, Laura
    Motzer, Robert J.
    Negrier, Slyvie
    Andresen, Steven W.
    Bukowski, Ronald M.
    CANCER, 2006, 107 (08) : 1793 - 1800
  • [38] Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma
    Kwak, Cheol
    Park, Yong Hyun
    Jeong, Chang Wook
    Jeong, Hyeon
    Lee, Sang Eun
    Moon, Kyung Chul
    Ku, Ja Hyeon
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (04) : 317 - 323
  • [39] Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma
    Kwak, Cheol
    Park, Yong Hyun
    Jeong, Chang Wook
    Jeong, Hyeon
    Lee, Sang Eun
    Ku, Ja Hyeon
    TUMORI JOURNAL, 2007, 93 (01): : 68 - 74
  • [40] Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Tsimafeyeu, Ilya V.
    Demidov, Lev V.
    Madzhuga, Albina V.
    Somonova, Oksana V.
    Yelizarova, Anna L.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
12345